Stay updated on Cabometyx + Avelumab in mRCC Clinical Trial
Sign up to get notified when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.

Latest updates to the Cabometyx + Avelumab in mRCC Clinical Trial page
- ChecktodayChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1. The study record still shows a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error with the standard header and footer, indicating access to the study record is blocked. This reflects a permission/availability issue rather than an update to substantive study content.SummaryDifference18%

- Check56 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6. This reflects a minor version update in the documentation system and does not alter visible content.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.6.5 was added. A large set of core terms including drug names and disease terms were removed from the study record's indexing fields, altering how the trial is described and surfaced in searches.SummaryDifference17%

Stay in the know with updates to Cabometyx + Avelumab in mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.